Pneumococcal Vaccine and Vaccination
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 28 February 2027 | Viewed by 599
Editor
Special Issue Information
Dear Colleagues,
This Special Issue focuses on the next generation of pneumococcal disease prevention. It highlights research addressing critical future challenges: the development of protein-based vaccines as broader alternatives; surveillance of serotype shifts and replacement disease risk post-vaccination; and evidence for regionally tailored strategies accounting for local epidemiology and resources. This Special Issue also welcomes evaluations of vaccine impact, cost-effectiveness, dynamic disease modeling for policy decisions, and innovations for equitable implementation. By integrating multidisciplinary perspectives, it aims to inform the evolving global agenda toward more effective, accessible, and context-specific pneumococcal immunization.
Dr. Mark Hermannes Rozenbaum
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pneumococcal conjugate vaccines
- immunization programs
- health technology assessment (HTA)
- cost-effectiveness analysis
- disease transmission models (DTMs)
- antimicrobial resistance (AMR)
- number needed to vaccinate (NNV)
- pediatric and adult vaccination
- global vaccine policy
- reimbursement strategies
- vaccine uptake and coverage
- real-world evidence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
